News

Old Antidepressant Offers Promise In Treating Heart Failure - 01/05/2010

A team of Johns Hopkins and other researchers have found in animal experiments that an antidepressant developed over 40 years ago can blunt and even reverse the muscle enlargement and weakened pumping function associated with heart failure.

Antidepressant use common in IBD | 6minutes

Antidepressant use is common among people with inflammatory bowel disease, an Australian study shows.

Generalized Anxiety Disorders (GAD) Therapeutics | PRLog

Generalized Anxiety Disorders (GAD) Therapeutics. GAD Therapeutics Market is Forecast to Show Low Growth until 2018 - PR11766768

AstraZeneca AB Slumps as Depression Drug Developed

WINSTON-SALEM, N.C.----AstraZeneca and Targacept, Inc. today announced top-line results from the second of four RENAISSANCE Phase 3 studies

Personalized Medicine Offers New Hope to People With Depression

New Genetic Assay from Genomind Can Guide Physicians in Choosing the Best Treatment for Their Patients

Forest Laboratories Management Discusses Q2 2012 Results - Earnings Call Transcript - Seeking Alpha

< p > Forest Laboratories ( < a href='http://seekingalpha.com/symbol/frx' title='Forest Laboratories, Inc.' > FRX < /a > ) < /p > < p > Q2 2012 Earnings Call < /p > < p > October 18, 2011 10:00 am ET < /p > < p > < strong > Executives < /strong > < /p > < p > Francis I. Perier - Chief Financial

Scotland in the grip of depression - Scotsman.com News

Scotland in the grip of depression - THE number of Scots prescribed pills to combat depression has soared to record levels, with more than one in ten people now regularly taking antidepressant drugs.

amednews: Antidepressants increasingly prescribed for nonpsychiatric conditions :: Aug. 22, 2011

Patients had gone to their doctors complaining of headaches, fatigue and ailments other than depression.

Launch of Lexapro commenced in Japan | Pharma Asia

H Lundbeck A/S announced that its partners Mochida Pharmaceutical Co Ltd and Mitsubishi Tanabe Pharma Corporation (MTPC) have launched Lexapro 10mg (escitalopram) in Japan, for which Mochida obtained the marketing approval following the NHI (National Health Insurance) drug price listing.

Medical News: APA: Folate Form May Up Response in Depression - in Meeting Coverage, APA from

HONOLULU -- For patients with major depressive disorder who don't respond to selective serotonin reuptake inhibitors, adding a folate metabolite may improve outcomes, researchers say.

Results 1-10 of 689
 


Refine by Content Type:

  • Refined by: News  


Refine by Source:

35 Sources ...